MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Multiple system atrophy(MSA): Clinical features"

  • 2016 International Congress

    Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, I. Kacem, Y. Sidhom, A. Gargouri, R. Gouider (Tunis, Tunisia)

    Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…
  • 2016 International Congress

    Multiple system atrophy: A comparison between clinical subtypes

    L.B. Barcelos, R.A. Saba, S.M.A. Silva, V. Borges, H.B. Ferraz (Sao Paulo, Brazil)

    Objective: To evaluate the cognitive impairment and sleep disturbances in subtype MSA-P versus MSA-C. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of…
  • 2016 International Congress

    A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders

    C. Raccagni, H. Gassner, S. Eschlböck, S. Bösch, F. Krismer, M. Nocker, K. Seppi, W. Poewe, J. Klucken, G. Wenning (Innsbruck, Austria)

    Objective: Primary objective was to identify quantitative markers of gait impairment in patients with idiopathic Parkinson's disease (IPD), atypical Parkinsonian disorders (APD) and healthy controls…
  • 2016 International Congress

    Dat-SPECT in multiple system atrophy (MSA)

    I. Toyoshima, T. Hatakeyama, Y. Takeda, K. Obara, M. Kobsysdhi, C. Wada (Yurihonjo, Japan)

    Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum with the patients with MSA, and compared between subtypes and disease duration…
  • 2016 International Congress

    MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials

    F. Krismer, G.K. Wenning, S. Bajaj, M. Schocke, C. Scherfler, W. Poewe, K. Seppi (Innsbruck, Austria)

    Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…
  • 2016 International Congress

    PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes

    J. Woodside, R. Lamb, V. Chelban, D. Burn, A. Church, A. Gerhard, M. Hu, N. Leigh, J. Rowe, H. Houlden (London, United Kingdom)

    Objective: To aid the development of curative treatments, we need to develop better methods for diagnosing Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Multiple…
  • 2016 International Congress

    Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?

    M. Schuberth, G. Nübling, J. Hauer, T. Marquardt, S. Lorenzl (München, Germany)

    Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…
  • 2016 International Congress

    Spinal fluid biomarkers for multiple system atrophy – A pilot study

    W. Singer, A. Schmeichel, D.M. Goldstein, J.D. Schmelzer, A.D. Zeller, T.L. Gehrking, P.A. Low (Rochester, MN, USA)

    Objective: To evaluate a comprehensive panel of cerebral spinal fluid (CSF) markers in multiple system atrophy (MSA) to define those with potential as future disease…
  • 2016 International Congress

    Clinical and polysomnographic features correlates to sleep-disordered breathing in multiple system atrophy

    B. Cao, Q. Wei, R. Ou, B. Zhao, T. Hu, H. Shang (Chengdu, People's Republic of China)

    Objective: The purpose of this study is to elucidate whether sleep-discorded breathing (SDB) impact motor and non-motor symptoms in multiple system atrophy (MSA), and to…
  • 2016 International Congress

    Esophageal involvement in multiple system atrophy

    T. Shimohata, H. Taniguchi, H. Nakayama, K. Hori, M. Inoue, M. Nishizawa (Niigata, Japan)

    Objective: To determine the prevalence of esophageal involvement and its impact on clinical manifestations in patients with multiple system atrophy (MSA). Background: Secondary motor disorders…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley